DK1664123T3 - Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf - Google Patents

Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf

Info

Publication number
DK1664123T3
DK1664123T3 DK04770552T DK04770552T DK1664123T3 DK 1664123 T3 DK1664123 T3 DK 1664123T3 DK 04770552 T DK04770552 T DK 04770552T DK 04770552 T DK04770552 T DK 04770552T DK 1664123 T3 DK1664123 T3 DK 1664123T3
Authority
DK
Denmark
Prior art keywords
months
api
alpha
scale production
proteinase inhibitor
Prior art date
Application number
DK04770552T
Other languages
English (en)
Other versions
DK1664123T4 (da
Inventor
Shabtai Bauer
Original Assignee
Kamada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34379546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1664123(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from IL15805303A external-priority patent/IL158053A0/xx
Application filed by Kamada Ltd filed Critical Kamada Ltd
Application granted granted Critical
Publication of DK1664123T3 publication Critical patent/DK1664123T3/da
Publication of DK1664123T4 publication Critical patent/DK1664123T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04770552.0T 2003-09-22 2004-09-22 Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf DK1664123T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50390203P 2003-09-22 2003-09-22
IL15805303A IL158053A0 (en) 2003-09-22 2003-09-22 Process for large scale purification of alpha-1 proteinase inhibitor
PCT/IL2004/000881 WO2005027821A2 (en) 2003-09-22 2004-09-22 Large scale preparation of alpha-1 proteinase inhibitor and use thereof

Publications (2)

Publication Number Publication Date
DK1664123T3 true DK1664123T3 (da) 2008-07-28
DK1664123T4 DK1664123T4 (da) 2012-03-05

Family

ID=34379546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04770552.0T DK1664123T4 (da) 2003-09-22 2004-09-22 Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf

Country Status (12)

Country Link
US (2) US7879800B2 (da)
EP (1) EP1664123B2 (da)
AT (1) ATE391730T1 (da)
CA (1) CA2538998C (da)
DE (1) DE602004013021T3 (da)
DK (1) DK1664123T4 (da)
ES (1) ES2305845T5 (da)
IL (1) IL174410A0 (da)
PL (1) PL1664123T5 (da)
PT (1) PT1664123E (da)
SI (1) SI1664123T2 (da)
WO (1) WO2005027821A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0524432D0 (en) 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
PT1981572E (pt) 2006-02-09 2013-02-26 Pari Pharma Gmbh Distribuição pulmonar de inibidor de alfa-i proteinase
WO2009025754A2 (en) 2007-08-17 2009-02-26 Csl Behring Gmbh Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
AU2009270723A1 (en) * 2008-07-18 2010-01-21 Grifols Therapeutics Inc. Method of preparing alpha-1 proteinase inhibitor
PT2496246T (pt) 2009-11-03 2018-07-31 Grifols Therapeutics Llc Composição, método e kit para o inibidor da alfa-1 protease
RU2540480C2 (ru) 2009-11-24 2015-02-10 Грифольс Терапьютикс Инк. Способы, композиции и наборы для лиофилизации
EP2714093A1 (en) 2011-05-27 2014-04-09 Baxter International Inc. Therapeutic proteins with increased half-life and methods of preparing same
MX351189B (es) 2011-12-30 2017-10-04 Grifols Sa Inhibidor de alfa1-proteinasa para demorar el comienzo o progresión de exacerbaciones pulmonares.
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
EP3565584A4 (en) * 2016-12-22 2021-01-06 Kamada Ltd. DRY POWDER FORMULATIONS OF ALPHA-1-ANTITRYPSINE
CA3054267A1 (en) * 2017-02-21 2018-08-30 Kamada Ltd. Methods and uses of alpha 1-antitrypsin for early intervention in pulmonary diseases
EP3723790B1 (en) 2017-12-12 2024-03-13 Kamada Ltd Methods of inducing immune tolerance and reducing anti-drug antibody response
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it
WO2020157752A1 (en) * 2019-01-29 2020-08-06 Kamada Ltd Pharmaceutical aerosol composition

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379087A (en) 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4439358A (en) 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4683294A (en) 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
US4697003A (en) * 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
US4749783A (en) 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
US5114917A (en) 1986-12-24 1992-05-19 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin
EP0534978B1 (en) 1990-05-01 1999-03-24 Chiron Corporation Interleukin-1 antagonist and uses thereof
US5814225A (en) 1994-06-09 1998-09-29 Shanbrom Technologies Llc Iodinated gel filtration media for disinfecting protein solutions
US6284874B1 (en) 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
EP0871671A1 (en) 1995-09-07 1998-10-21 PPL Therapeutics (Scotland) Limited Purification of alpha-1 proteinase inhibitor
US5780440A (en) 1996-06-17 1998-07-14 Protease Sciences Inc. Treatment of pulmonary disease with protease inhibitors
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
AT407114B (de) 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung
US6093804A (en) * 1998-09-24 2000-07-25 American National Red Cross Method for purification of alpha-1 proteinase inhibitor
US6462180B1 (en) * 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
NZ526940A (en) 2000-12-14 2005-06-24 Bayer Healthcare Llc Method of preparing alpha-1 proteinase inhibitor
DK1501369T3 (da) 2002-04-26 2015-09-28 Genentech Inc Ikke-affinitetsoprensning af proteiner
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
CA2534900A1 (en) 2003-08-12 2005-02-17 Octapharma Ag Process for preparing an alpha-1-antitrypsin solution
EP1765866B1 (en) 2004-06-07 2014-01-08 Therapure Biopharma Inc. Isolation of plasma or serum proteins

Also Published As

Publication number Publication date
SI1664123T2 (sl) 2012-03-30
SI1664123T1 (sl) 2008-10-31
EP1664123B2 (en) 2011-11-30
CA2538998C (en) 2015-11-24
DE602004013021D1 (de) 2008-05-21
US7879800B2 (en) 2011-02-01
DK1664123T4 (da) 2012-03-05
WO2005027821A2 (en) 2005-03-31
DE602004013021T2 (de) 2009-06-25
ES2305845T5 (es) 2012-04-12
US20110092444A1 (en) 2011-04-21
EP1664123B1 (en) 2008-04-09
EP1664123A4 (en) 2006-11-02
EP1664123A2 (en) 2006-06-07
DE602004013021T3 (de) 2012-04-05
AU2004273696A1 (en) 2005-03-31
PT1664123E (pt) 2008-07-16
WO2005027821A3 (en) 2005-08-04
ATE391730T1 (de) 2008-04-15
IL174410A0 (en) 2006-08-01
PL1664123T5 (pl) 2012-04-30
ES2305845T3 (es) 2008-11-01
US20080139465A1 (en) 2008-06-12
CA2538998A1 (en) 2005-03-31
PL1664123T3 (pl) 2008-11-28

Similar Documents

Publication Publication Date Title
DK1664123T4 (da) Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
SG166791A1 (en) Novel macrocyclic inhibitors of hepatitis c virus replication
NO20056010L (no) Biaryloksymetylaren-karboksylsyrer
EA200201271A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
TN2009000481A1 (en) Novel peptide inhibitors of hepatitis c virus replication
SE0302487D0 (sv) Novel compounds
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
TW200510391A (en) Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
HUP0300850A2 (hu) Gyűrűs béta-aminosav-származékok mint mátrix metalloproteázok és a TNF-alfa inhibitorok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE457310T1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO20076425L (no) Fremgangsmater for behandling av drug-resistent cancer
TW200720270A (en) Novel cyclic amines
BRPI0515081B8 (pt) composto, processo para a preparação de um sal de guanidino trifluormetilaroil amida, processo para a preparação de um fenil amino pirido pirimidina, composições farmacêuticas e processos para preparar (3,5-bis trifluormetil)-n-[4-metil-3-(4-piridin-3-il-pirimidin-2-ilamino)-fenil]-benzamida
BR0308765A (pt) Compostos (4,2-dissubstituìdo-tiazol-5-il)amina como inibidores de pde7
ATE479433T1 (de) Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
SE9904421D0 (sv) New compounds
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
MX2007006744A (es) Derivados de hidantoina utiles como inhibidores de metaloproteinasa.
BR0308807A (pt) Compostos tiazol-2-il-imina como inibidores de pde-7
SE0101978D0 (sv) New compounds
DE602005020314D1 (de) Bicyclononen-derivate als renin-inhibitoren
BRPI0501769A (pt) Compostos de pirrolidina e tiazolidina, processo para sua preparação e composições farmacêuticas contendo os mesmos
SE9904676D0 (sv) Novel compounds